AG
IMGN

Artal Group’s Immunogen Inc IMGN Stock Holding History

Artal Group’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-600,000
Closed -$5.37M – 90
2015
Q1 		$5.37M Sell
600,000
-400,000
-40% -$2.9M 0.25% 56
2014
Q4 		$6.1M Buy
1,000,000
+600,000
+150% +$5.49M 0.21% 62
2014
Q3 		$4.24M Sell
400,000
-150,000
-27% -$1.7M 0.16% 64
2014
Q2 		$6.52M Buy
550,000
+200,000
+57% +$2.51M 0.26% 58
2014
Q1 		$5.23M Hold
350,000
– – 0.19% 69
2013
Q4 		$5.13M Buy
350,000
+50,000
+17% +$768K 0.18% 59
2013
Q3 		$5.11M Hold
300,000
– – 0.17% 56
2013
Q2 		$4.98M Buy
+300,000
New +$4.86M 0.16% 68

Other funds holding IMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Artal Group's IMGN Position: Q4 2023 in Review

Artal Group sold out of Immunogen Inc (IMGN) in Q4 2023, closing a stake of 1,512,113 shares — an estimated $24M sold.

Artal Group first reported a position in IMGN in Q2 2013 and held it in 8 quarters. The position peaked at $28.2M in Q2 2013. 327 funds tracked by Wall St. Rank hold IMGN as of Q4 2023.

  • Artal Group reported no remaining Immunogen Inc position as of Q4 2023 after selling out during the quarter.
  • Artal Group sold 1,512,113 Immunogen Inc shares in Q4 2023, an estimated $24M.
  • Artal Group first reported a position in Immunogen Inc in Q2 2013 and held it in 8 quarters.
  • Artal Group's Immunogen Inc position peaked at $28.2M in Q2 2013.
  • 327 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2023.

Based on Artal Group's 13F filing for Q4 2023, filed 9 Feb 2024.